Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Reports from University of Pennsylvania add new data to research in cancer vaccines
February 25th, 2009
"Human papillomavirus infection, the most common sexually transmitted infection in the United States, is associated with the development of cervical cancer," scientists in the United States report. "The new human papillomavirus vaccine advances cervical cancer prevention; however, provider-recommended screening with Papanicolaou tests and lifestyle modifications are still needed. Widespread implementation of the vaccine and delivering cervical cancer screening to underserved populations remain a challenge," wrote A.M. Teitelman and colleagues, University of Pennsylvania. The researchers concluded: "Nurses are ideally suited to address these needs by...
Source: Vaccine Weekly (2009-02-25)
|